Relapse of nephrotic syndrome triggered by biphosphonates [6]

Nephrology Dialysis Transplantation

Volumn 17, Issue 10, 2002, Pages 1856-1857

  Stratton, Jon D ^a   Warwicker, Paul ^a  

^a Lister Renal Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETIDRONIC ACID; LEVAMISOLE; MIFEPRISTONE; PREDNISOLONE; RIFAMYCIN DERIVATIVE; STEROID;

ACUTE KIDNEY FAILURE; ADULT; BONE MARROW SUPPRESSION; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG METABOLISM; DRUG WITHDRAWAL; HUMAN; KIDNEY BIOPSY; LETTER; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NEPHROTOXICITY; OSTEOPENIA; PRIORITY JOURNAL; RELAPSE;

ADULT; DIPHOSPHONATES; HUMANS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; RECURRENCE;

EID: 0036797841     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Alden CL, Burns JL, Parler RD et al. Characterization of the early ultrastructure and biochemical events occurring in dichloromethane diphosphonate nephrotoxicity. Toxicol Pathol 1990; 18: 661-666
2. Alden CL, Parker RD, Eastman DF. Development of an acute model for the study of chloromethane diphosphonate nephrotoxicity. Toxicol Pathol 1989; 17: 27-32
3. Pecherstorfer M, Ludwig H, Schlosser K et al. Administration of the bisphosphonate ibandronate (BM21.0955) by intravenous bolus injection. J Bone Miner Res 1996; 11: 587-593
4. Markowitz GS, Appel GB, Fine PL et al. Collpasing focal segmental glomerulosclerosis following treatment with high dose pamidronate. J Am Soc Nephrol 2001; 12: 1164-1172